Merit Medical Systems, Inc., a leading healthcare technology firm, has announced an asset purchase agreement with EndoGastric Solutions, Inc. valued at approximately $105 million. The acquisition includes EndoGastric Solutions’ EsophyX Z+ device, a minimally invasive solution for chronic gastroesophageal reflux disease (GERD). This transaction is projected to add $30 million in annualized revenue to Merit’s gastrointestinal endoscopy market. Merit anticipates short-term dilution in its GAAP net income for 2024 but expects long-term accretion in non-GAAP gross and operating margins, net income, and earnings per share. The acquisition supports Merit’s strategic goal of expanding its endoscopy portfolio and solidifying its presence in the multi-billion-dollar gastrointestinal market. This growth is anticipated despite initial non-GAAP financial impacts and continued strategies for integration and expanded market presence.

Healthcare Technology, Medical Devices,United States